Is Adjuvant Radiotherapy Effective in Intermediate-risk Surgical Stage I Endometrial Cancer?

Is Adjuvant Radiotherapy Effective in Intermediate-risk Surgical Stage I Endometrial Cancer?

Objective: To better understand the potential risks and benefits of adjuvant radiotherapy in patients with intermediate-risk surgical stage I endometrial cancer. Materials and Methods: A retrospective chart review identified 55 patients with endometrial carcinoma stage IA grade 3, stage IB grade 2,...

Full description

Bibliographic Details
Main Authors:	Hung-Chuan Yu, Chi-Mou Juang, Ching-Ying Huang, Nae-Fang Twu, Ming-Shyen Yen
Format:	Article
Language:	English
Published:	Elsevier 2004-06-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Subjects:	adjuvant radiotherapy endometrial cancer stage I intermediate risk overall survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455909600644

Similar Items

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
by: Hariyono Winarto, et al.
Published: (2022-11-01)

Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
by: Xi-Lin Yang, et al.
Published: (2022-10-01)

Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer
by: Yasin Durmus, et al.
Published: (2018-08-01)

Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study
by: Jenny Ling-Yu Chen, et al.
Published: (2020-04-01)

Improved disease-free survival with adjuvant radiotherapy in early-stage endometrial cancer: 10-year outcome analysis
by: Suheyla Arslan, et al.
Published: (2020-12-01)

Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study
by: Kang Ren, et al.
Published: (2022-10-01)

Adjuvant Radiotherapy Improved Survival in Stage I to II Low-Grade Endometrial Stromal Sarcoma: A Retrospective Study of 152 Cases
by: Wenhui Wang, et al.
Published: (2021-01-01)

Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two‐center study
by: Wenjie Ni, et al.
Published: (2019-06-01)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2022-09-01)

Five-year disease-free survival in FIGO IA stage endometrial cancer patients: Tertiary institution experience in a developing country
by: Marija Živković Radojević, et al.
Published: (2023-10-01)

Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities
by: Gonçalo Nogueira-Costa, et al.
Published: (2022-01-01)

Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy
by: María Alonso-Espías, et al.
Published: (2023-10-01)

Survival, Failure Patterns, and Toxicity Outcomes in Endometrial Cancer Patients Receiving Adjuvant Radiotherapy
by: Sedef Gökhan Açıkgöz, et al.
Published: (2023-09-01)

Long-term survival outcomes of laparoscopic staging surgery in treating endometrial cancer: 20 years of follow-up
by: Chyi-Long Lee, et al.
Published: (2016-08-01)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
by: Isao Otsuka, et al.
Published: (2022-05-01)

Stage IB Endometrioid Type Endometrial Cancer: The Role of Lymphadenectomy and Adjuvant Radiation Therapy
by: Osman Turkmen, et al.
Published: (2018-12-01)

Does obesity hinder radiotherapy in endometrial cancer patients? The implementation of new techniques in adjuvant radiotherapy – focus on obese patients
by: Małgorzata Moszyńska-Zielińska, et al.
Published: (2014-05-01)

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)

Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study
by: Shuangli Zhang, et al.
Published: (2023-11-01)

Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China
by: Wenhui Wang, et al.
Published: (2022-03-01)

Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group Study
by: Yoav Brezinov, et al.
Published: (2022-06-01)

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
by: Rebecca C. Arend, et al.
Published: (2021-11-01)

Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer
by: Liwen Wang, et al.
Published: (2020-08-01)

The Relationship of Myometrial Invasion Between Other Prognostic Parameters in Endometrial Cancer
by: Mehmet Sait Bakır, et al.
Published: (2017-12-01)

Optimal Management for Stage IVB Endometrial Cancer: A Systematic Review
by: Vito Andrea Capozzi, et al.
Published: (2023-10-01)

Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
by: Zhang YF, et al.
Published: (2021-04-01)

Adjuvant Radiotherapy after Surgical Excision in Keloids
by: Jeong Won Lee, et al.
Published: (2021-07-01)

Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy
by: Gui-Fen Ma, et al.
Published: (2024-01-01)

Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer
by: Eva Meixner, et al.
Published: (2022-05-01)

Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
by: Xinyu Wang, et al.
Published: (2018-11-01)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
by: Daniel Wegener, et al.
Published: (2022-09-01)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
by: Annamaria Ferrero, et al.
Published: (2022-11-01)

The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021-05-01)

The Results and Outcomes of Rectal Cancer Treatment in the Era of Adjuvant Chemoradiation
by: Ahmad Izadpanah, et al.
Published: (2019-12-01)

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T4, N2 disease, positive resection margin, and receiving adjuvant chemotherapy
by: Lili Wu, et al.
Published: (2023-07-01)

Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer
by: Hsin-Hua Nien, et al.
Published: (2022-09-01)

Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme
by: Menal Bhandari, et al.
Published: (2017-05-01)

Adjuvant therapy and prognosis in uterine carcinosarcoma
by: Chi-Yuan Chiang, et al.
Published: (2021-11-01)

The clinico pathological features and survival in serous endometrial cancers
by: Amrita Datta, et al.
Published: (2023-06-01)

Fiducial markers in adjuvant setting for a patient affected by endometrial cancer: a case report
by: Francesca Titone, et al.
Published: (2023-08-01)